Why is Gland Pharma falling/rising?

As of 14-Jul, Gland Pharma Ltd's stock price is currently at 1,888.60, reflecting an increase of 30.7 points or 1.65%. The stock has been gaining momentum, having risen 2.81% over the last two days and outperforming its sector by 0.75% today. It reached an intraday high of Rs 1,933.9, which is a 4.09% increase. Over the past month, Gland Pharma has shown a return of 11.66%, while its year-to-date performance stands at 5.59%. The company benefits from a low debt-to-equity ratio and high institutional holdings at 40.18%, which suggests strong investor confidence and capability in analyzing the company's fundamentals.
In the broader market context, Gland Pharma's recent performance contrasts with the Sensex, which has declined by 1.42% over the past week. While Gland Pharma has shown positive returns in the short term, its one-year performance is down by 7.36%, indicating some longer-term challenges. However, the stock's ability to trade above its moving averages and the significant increase in delivery volume suggest a growing interest among investors, contributing to its upward price movement despite the broader market's struggles.